Exciting Advances in Cancer Treatment Shared at 2025 ASCO Annual Meeting The 2025 ASCO Annual Meeting showcased promising data from clinical trials on ADC candidates from Duality Bio, enhancing cancer treatment options.

Exciting Advances in Cancer Treatment Shared at 2025 ASCO Annual Meeting #USA #Chicago #ASCO_2025 #Duality_Bio #ADC_Candidates

Duality Bio Reveals Promising Clinical Data at 2025 ASCO Annual Meeting for ADC Candidates At the 2025 ASCO Annual Meeting in Chicago, Duality Bio showcased early data from two promising ADC clinical trials targeting CRPC and advanced solid tumors.

Duality Bio Reveals Promising Clinical Data at 2025 ASCO Annual Meeting for ADC Candidates #United_States #Chicago #Duality_Bio #ADC_Candidates #ASCO_Annual_Meeting